Multiplex RT-PCR analysis of human cytomegalovirus (HCMV) replication in human fibroblasts
showed transcription of the natural killer (NK) cell decoy gene, UL18, from 72 h onwards. Transcription of glycoprotein B (gpUL55 ; a late gene) occurred from early time-points and peaked at 24 h post-infection. UL18 mRNA was also detected in the peripheral blood mononuclear cells of organ transplant recipients with HCMV viraemia, especially those with HCMV DNA virus loads greater than 10 5 genomes/ml whole blood. Thus, UL18 is produced via a low abundance transcript late during the infectious cycle at a time coincidental with the increased risk of NK cell lysis as a consequence of class I HLA down-regulation.
Human cytomegalovirus (HCMV) infection is common, but in the immunocompetent individual the infection is mostly asymptomatic. However, the virus poses a risk to an unborn foetus and to immunocompromised individuals such as those infected with the human immunodeficiency virus and transplant recipients receiving immunosuppressive therapy (reviewed by Griffiths & Emery, 1997) .
Like other viruses, HCMV has evolved many mechanisms to evade and interfere with the host's immune responses (Spriggs, 1996) . One of these mechanisms aims to reduce cell surface expression of major histocompatibility complex (MHC) class I and prevent antigen presentation to CD8 + cytotoxic T lymphocytes (CTLs ; Barnes & Grundy, 1992 ; Beersma et al., 1993 ; Hengel et al., 1996 ; Riddell & Greenberg, 1997) . HCMV encodes four proteins, US2, US3, US6 and US11, which interfere in class I HLA transport and presentation. Expression of US2 destabilizes the MHC class I heavy chain ; the US3 protein interferes with the maturation and transport of the class I heavy chain by associating with the β # microglobulin-heavy chain complex in the endoplasmic reticulum (ER) and preventing its transport out of the ER Ahn et ., 1996) ; and US11 facilitates the transport of MHC molecules out of the ER into the cytosol, where they are degraded by Nglycanase and proteosomes Jones et al., 1995) . The US6 protein impairs TAP function by inhibiting the transport of cytosolic peptides across the membrane of the ER into the lumen (Hengel et al., 1996 ; Reyburn et al., 1997) .
As a consequence of this class I HLA down-regulation, cells should become susceptible to natural killer (NK) lysis due to the ' missing-self hypothesis ' (Ljunggren & Ka$ rre, 1990) . Recent data have shown that another HCMV gene product, UL18, is able to act as a broad spectrum NK decoy by binding to an NK-inhibitory receptor (Reyburn et al., 1997) . NK inhibitory receptors normally recognize MHC class I molecules and protect the uninfected host cell from NK attack. UL18 is homologous to the MHC class I heavy chain of higher organisms (Beck & Barrell, 1988) , binds β # microglobulin (MHC class I light chain ; Browne et al., 1990) , and can present endogenous peptides on the cell surface (Chapman & Bjorkman, 1998) . UL18 binds to the c-type lectin CD94 inhibitory receptor on human NK cells and prevents NK lysis of the HCMV-infected cell (Reyburn et al., 1997) .
In the allograft recipient the administration of drugs such as cyclosporin A, which decreases CTL responses, coupled with down-regulation of HLA display on virus-infected target cells may well abrogate the function of this component of the cellmediated immune response, so that NK cells may play an important role in defence. To determine if transcription of the UL18 gene occurs at a time consistent with the interference of NK function, and to determine whether the gene is transcribed in vivo, we conducted temporal studies of expression in vitro and used RT-PCR to detect UL18 transcripts in the peripheral blood mononuclear cells (PBMCs) of patients with HCMV viraemia.
Multiplex RT-PCR analysis was performed on RNA extracted from a time-course of AD169 (HCMV wild-type)-infected human fibroblasts (m.o.i. of 0n5) to identify the temporal appearance of UL18 mRNA transcripts. The sensitivity of UL18 PCR was determined by performing a multiplex glycoprotein B (gB, gpUL55) and UL18 PCR amplification. UL18 primers (UL18A and UL18B) were shown to be as sensitive as our previously published gB primers (10 copies of DNA target). As a control, the appearance and quantity of gB mRNA was also assessed by RT quantitative 0001-5536 # 1998 SGM CBBD A. F. Hassan-Walker and others A. F. Hassan-Walker and others Fig. 1 . Human embryo lung fibroblasts were infected with HCMV strain AD169 (m.o.i. of 0n5). Total RNA and DNA were extracted at time-points 0, 6, 12, 24, 48, 72 and 96 h p.i. using the RNeasy kit (Qiagen) and the genomic DNA extraction kit (Promega) respectively. (a) Multiplex RT-PCR analysis for the temporal appearance of UL18 and gB mRNA transcripts at the above time-points. RT-PCR was performed using the GeneAmp RNA PCR kit (Perkin Elmer). Total RNA (1 µg) was reversetranscribed with an oligo(dT) 16 primer (42 mC, 15 min ; 99 mC, 5 min ; 5 mC, 5 min) and PCR-amplified using UL18 primers located at the 3h end of the gene : sense-strand primer, UL18A (24394-24409), 5h ATAGCGAGCCTCAATG 3h ; antisensestrand primer, UL18B (24590-24569), 5h GTTAGCTGTCGGGTGATCAGGG 3h. The gB primers used were gB1, sense-strand primer (81683-81707), 5h GAGGACAACGAAATCCTGTTGGGCA 3h ; gB2, antisense-strand primer (81580-81558), 5h GTCGACGGTGGAGATACTGCTGAGG 3h. An initial denaturation at 95 mC for 5 min was followed by 94 mC (30 s) denaturing, 60 mC (30 s) annealing and 72 mC (30 s) extension for 40 cycles, with a final extension at 72 mC for 10 min. ' M ' denotes the PCR marker (Promega). (b) Graph to show HCMV RNA and DNA loads at 0, 6, 12, 24, 48, 72 and 96 h p.i. RT-PCR was performed using the Access RT-PCR system (Promega). This protocol utilized an optimized buffer which allowed RT-PCR amplification of gB mRNA to be performed with all the necessary components for the reverse transcription step and QCPCR amplification to be added in a single reaction mix. AD169 total RNA (1 µg) was reverse-transcribed with gB2, and PCRamplified with gB1 and gB2. gB mRNA and DNA loads were quantified by RT-QCPCR and QCPCR using a gB internal control (Fox et al., 1992) .
competitive PCR (RT-QCPCR). All RNA samples were DNase I-treated and RT-PCR amplifications were performed in the absence of reverse transcriptase to ensure that RNA samples were DNA-free. RT-QCPCR for gB was carried out as standard RT-PCR amplifications but with the inclusion in each reaction of a known copy number of internal control plasmids containing a mutated gB sequence (Fox et al., 1992) that was competitively amplified with the target sequence. The results illustrated in Fig. 1 (a, b) show that whereas gB mRNA could be detected from 6 h post-infection (p.i.) and was maximal at 24 h p.i. (10' n ) copies\µg) when viral DNA levels were increasing exponentially, UL18 mRNA was not detected until 72 h p.i., at which time viral DNA levels were maximal and relatively static. The apparent discrepancy in gB mRNA between the 24 h time-point in Fig. 1 may reflect methodological differences (see legend) at the reverse transcription stage or a falsely low signal due to the presence of inhibitors. Importantly, Fig. 1 (a) clearly illustrates that the UL18 transcript was not detected until 72 h p.i., a considerable time after the appearance and maximal steady state levels of gB mRNA.
In order to ascertain whether UL18 mRNA could be detected during active HCMV infection in vivo, we performed RT-PCR for HCMV UL18 on DNase I-treated RNA extracted from the blood of bone marrow and liver transplant recipients with HCMV infection. The appropriate controls, as described above, were included in all UL18 RT-PCR analyses to confirm that RNA preparations were not contaminated with DNA. UL18 mRNA was detected in three out of 13 samples, two of which were from the same patient (no. 6 ; Fig. 2 a, b) . The presence of RNA in each sample was confirmed by amplifying mRNA human actin and HCMV gB (Table 1) . In patient 5, UL18 mRNA was detected in the first HCMV PCR-positive blood sample of the patient following liver transplantation, but not in the following two samples, even though blood was collected 3 and 6 days later (Fig. 2 b) . In patient 6, four consecutive HCMV PCR-positive samples were analysed (Fig.  2 b, A-D) . UL18 mRNA was detected in the first and fourth samples. These twelve samples were also tested for the presence of gB mRNA. All but four were positive for gB mRNA, indicating the presence of replicating virus in eight out of twelve samples. UL18 mRNA was detected in those samples that appeared to have high levels of gB mRNA. Therefore, the inability to detect UL18 mRNA in all the samples suggested that UL18 gene expression is transient and has a relatively low abundance.
The HCMV DNA virus load in these clinical samples was quantified using methods previously described (Fox et al., 1992) . UL18 was not detected in those patients with HCMV virus loads less than 10& genomes\ml whole blood (Table 1 ). The patient samples from which UL18 mRNA could be CBBE Transcription of HCMV UL18 in vitro and in vivo Transcription of HCMV UL18 in vitro and in vivo Fig. 2 . RT-PCR analysis for the detection of UL18 mRNA transcripts from (a) patients 2, 3, 4, 5 and 6, and (b) consecutive samples taken at 3-day intervals from patient 5 (A-C) and patient 6 (A-D). The 196 bp UL18 cDNA PCR product is indicated. PBMCs were isolated from 3 ml blood (Ficoll-Paque ; Pharmacia) from which total RNA was extracted (RNAzol B ; Biogenesis). RT-PCR cycling parameters and primers used for reverse transcription and UL18 PCR amplification were as described in Fig. 1 . ' M ' denotes the PCR marker (Promega).
detected all had high virus DNA loads (greater than 8i10& genomes\ml). However, even when high DNA loads were present ( 10& genomes\ml), UL18 mRNA was not consistently detected. The observation that UL18 mRNA was more likely to be detected in samples with high virus loads implies that transcription levels of the gene are low when compared with gB mRNA. Indeed, a high virus load in a sample does not necessarily reflect high levels of virus replication. Our transcription results are in agreement with the observations of Reyburn et al. (1997) , where levels of UL18 protein expression following transfection were low compared to the classical class I HLA-cw6 molecule, but the protein was as effective at inhibiting lysis by NK cells as the MHC class I molecules.
In conclusion, our results show that UL18 is transcribed in vivo but that transcripts were only detected in those samples with high DNA virus loads indicative of active replication and often transiently. This result is consistent with the proposed functional role of UL18 in vivo since, based upon its kinetics of synthesis, UL18 is produced only when very low levels ( 1 k k j 2 n 2 i 10$ 2A k j j 6 n 0 i 10% 2B k k j 2 n 2 i 10% 3 k j j 1 n 0 i 10$ 4 k k j 1 n 7 i 10$ 5A j j j 1 n 4 i 10' 5B k j j 1 n 2 i 10( 5C k k j 2 n 3 i 10& 6A j j j 8 n 8 i 10& 6B k j j 1 n 2 i 10( 6C k j j 3 n 3 i 10' 6D j j j 1 n 4 i 10' 20 % ; Barnes & Grundy, 1992 ; Grundy & Downes, 1993) of class I HLA on the surface of the infected cell are reached. Further experiments are in progress to ascertain whether UL18 transcription is restricted to specific cell types in blood and target organs.
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